phone iconPhone: (401) 822-4673
phone iconFax: (401) 822-4676
Receive our Health e-Newsletter

News for Healthier Living

Timing of Shingles Vaccine and JAK Inhibitor Initiation Can Affect Early Outcomes in Patients with Rheumatoid Arthritis

A randomized trial in patients with rheumatoid arthritis (RA) suggests that the timing of when a Janus kinase (JAK) inhibitor is initiated relative to administration of the shingles vaccine can affect early immune response to shingles and arthritis control.

July 20, 2026


August 1 2026

July 31 2026

July 30 2026

July 29 2026

July 28 2026

July 27 2026

July 26 2026

July 25 2026

July 24 2026

July 23 2026

July 22 2026

July 21 2026

July 20 2026

Angell Street Psychiatry
Copyright 2026 HealthBanks, Inc. All rights reserved.
Terms of Use | Privacy Policy